HTR1A and depressive symptom measurement: Suppression of 5-HT1A heteroreceptors (using the CAMKIIα promoter to target pyramidal neurons) would be predicted to increase pyramidal neuron firing and display an anxiety phenotype rather than depression according to the model proposed.